Biologics
-
Biologics
Bioventus Invests in CartiHeal with Option to Acquire
Companies have agreed on an option structure under which Bioventus will acquire CartiHeal shortly after FDA approval of the Agili-C implant.Bioventus 07.16.20
-
Biologics
FDA Clears Altapore Shape Bioactive Bone Graft
Designed to enhance bone growth and help achieve fusion.Business Wire 07.09.20
-
Biologics
Aziyo Biologics Launches OsteGro V
Company expands regenerative medicine product portfolio and leverages proprietary processing platform to protect and preserve native bone cells.Aziyo Biologics 07.02.20
-
Biologics
FDA Clears Strip Format of Bioventus’ Signafuse Bioactive Bone Graft
A bone graft substitute intended for use in bony voids or gaps of the skeletal system.Bioventus 06.25.20
-
Biologics
SIRAKOSS Receives U.S. FDA 510(k) Clearance for Osteo3 ZP Putty
Combines best-in-class bone repair with intraoperative ease-of-use for spine and trauma bone grafting applications.SIRAKOSS Ltd. 06.17.20
-
Biologics
Smith+Nephew's Regeneten Bioinductive Implant Receives CE Mark
Supports the body's natural healing response to facilitate tissue growth for rotator cuff repairs.PR Newswire 06.16.20
-
Biologics
Academia: The Main Innovation Source for Orthobiologics
Smith+Nephew has formed a Biologics and Regenerative Medicine R&D team dedicated to development of innovative orthobiologic products.Online Exclusives Michael Barbella, Managing Editor 06.05.20
-
Biologics
Surgeon Creativity Shaping Orthobiologics Innovation
Good relationships with surgeon customers can lead to collaborative development efforts.Online Exclusives Michael Barbella, Managing Editor 05.29.20
-
Biologics | Spine/Neurology
Cerapedics Releases i-FACTOR Peptide Enhanced Bone Graft Lumbar Fusion Trial Results
Elderly patients undergoing non-instrumented fusion achieve statistically significantly higher fusion rate.PR Newswire 05.19.20
-
Biologics | Spine/Neurology
VIVEX Biologics Publishes Initial Clinical Results of VIA Disc
The firm has designed a disc matrix allograft that may offer patients the first non-surgical approach for treating DDD.Globe Newswire 04.30.20
-
Biologics
BONESUPPORT Appoints General Manager and Executive VP
Company's new manager has more than two decades of experience in the orthopedic industry.PR Newswire 04.30.20
-
Biologics
Biocomposites' STIMULAN Earns CE Mark
First calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft tissue.PR Newswire 04.23.20
-
Biologics
Konica Minolta Healthcare Expands Ultrasound Guided Solutions Through RegenLab Partnership
The bio-injectable line includes preparation devices for Platelet Rich Plasma and other blood cell therapies, delivered using ultrasound guidance.Konica Minolta Healthcare Americas Inc. 04.16.20
-
Biologics
Evonik Develops Fermentation-Based Collagen Platform
A substitute for animal-derived collagen in multiple markets.Evonik 03.25.20
-
Biologics | Large Joint
Bone Therapeutics Gains Approval to Trial OA Knee Pain Therapies
Regulatory authorities approve JTA Phase III study in osteoarthritic knee pain, ALLOB Phase IIb study in difficult fractures.Bone Therapeutics 03.25.20
-
Biologics
Made-to-Order Muscles Could Be Served in a Hospital Near You
Dr. Ali Tamayol recently developed a handheld bioprinter pen that could significantly change the way musculoskeletal procedures are performed.Sam Brusco, Associate Editor 03.13.20
-
Biologics
Bone Solutions Reaches 1,000-Implant Milestone for OsteoCrete
Product has a high compressive strength that is three times stronger than the average cancellous bone.PR Newswire 02.26.20
-
Biologics
Study: ARTEBONE Paste Similar to Patient's Own Bone Graft
In addition, the paste showed no safety concerns or product-related complications.Globe Newswire 02.21.20
-
Biologics
Nature’s Way: Promoting the Body's Curative Abilities Through Biologics
A better understanding of cell function, tissue properties, and healing mechanisms are driving growth in the global orthobiologics market.Michael Barbella, Managing Editor 02.18.20
-
Biologics
Bioventus Updates U.S. Label for Ultrasound Bone Healing System
EXOGEN has an 86 percent heal rate for fractures not healing on their own.Bioventus 02.10.20
